Platelet purinergic receptors.

Abstract:

:Activation of P2Y(1) and P2Y(12) receptors, through secreted ADP that is stimulated by agonists such as thrombin, thromboxane and collagen, is a major mechanism of platelet activation. P2X(1) receptors also participate in platelet shape change and potentiation of calcium mobilization. The cloning of the P2Y(12) receptor and its subsequent knockout in mice promises further understanding of its downstream signaling events.

journal_name

Curr Opin Pharmacol

authors

Kunapuli SP,Dorsam RT,Kim S,Quinton TM

doi

10.1016/s1471-4892(03)00007-9

keywords:

subject

Has Abstract

pub_date

2003-04-01 00:00:00

pages

175-80

issue

2

eissn

1471-4892

issn

1471-4973

pii

S1471489203000079

journal_volume

3

pub_type

杂志文章,评审
  • Retrieving GPCR data from public databases.

    abstract::Improvements in databases have already impacted GPCR research. The purpose of the review is to give a snapshot of the GPCR data available and provide utility examples. Consequently, this review covers a small set of major databases, including UniProt for proteins, Ensembl for genes, ChEMBL for bioactive chemistry and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.07.002

    authors: Southan C

    更新日期:2016-10-01 00:00:00

  • CGRP receptors in the control of pain and inflammation.

    abstract::Calcitonin gene related peptide (CGRP) has been proposed to contribute to pain transmission and inflammation and for these reasons to the mechanism of migraine. CGRP is, in fact, expressed in and released from a subset of polymodal primary sensory neurons of the trigeminal ganglion. Release of CGRP in the dorsal spina...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.12.007

    authors: Benemei S,Nicoletti P,Capone JG,Geppetti P

    更新日期:2009-02-01 00:00:00

  • Biased ligands: pathway validation for novel GPCR therapeutics.

    abstract::G protein-coupled receptors (GPCRs), in recent years, have been shown to signal via multiple distinct pathways. Furthermore, biased ligands for some receptors can differentially stimulate or inhibit these pathways versus unbiased endogenous ligands or drugs. Biased ligands can be used to gain a deeper understanding of...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.04.002

    authors: Rominger DH,Cowan CL,Gowen-MacDonald W,Violin JD

    更新日期:2014-06-01 00:00:00

  • Drugs acting on SUR1 to treat CNS ischemia and trauma.

    abstract::Sulfonylurea receptor 1 (SUR1) is a molecule with more diverse and critically important functions than previously recognized. Long viewed simply as a subunit involved in formation of a subset of K(ATP) channels, accumulating evidence indicates that SUR1 is newly upregulated in CNS ischemia and injury and is surprising...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章

    doi:10.1016/j.coph.2007.10.004

    authors: Simard JM,Woo SK,Bhatta S,Gerzanich V

    更新日期:2008-02-01 00:00:00

  • Therapeutic opportunities in the B7/CD28 family of ligands and receptors.

    abstract::The CD28 and B7 protein families are critical regulators of immune responses and, in the past few years, several new family members have been identified. Preclinical studies exploring the role of members of the CD28 and B7 families support the targeting of these pathways for new therapeutic approaches. Indeed, recent ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.003

    authors: Carreno BM,Carter LL,Collins M

    更新日期:2005-08-01 00:00:00

  • New therapeutics for osteoporosis.

    abstract::Two new approaches for the treatment of osteoporosis are summarized, each having arisen out of important new discoveries in bone biology. Odanacatib (ODN) inhibits the enzyme, cathepsin K, that is essential for the resorbing activity of osteoclasts. It is effective in preventing ovariectomy-induced bone loss in precli...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.03.004

    authors: Ng KW,Martin TJ

    更新日期:2014-06-01 00:00:00

  • Gene expression profiling in stroke: relevance of blood-brain interaction.

    abstract::Biomarker profiling is utilized to identify diagnostic and prognostic candidates for stroke. Clinical and preclinical biomarker data suggest altered circulating immune responses may illuminate the mechanisms of stroke recovery. However, the relationship between peripheral blood biomarker profile(s) and brain profiles ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.10.004

    authors: Asano S,Chantler PD,Barr TL

    更新日期:2016-02-01 00:00:00

  • OATP transporter-mediated drug absorption and interaction.

    abstract::Although oral administration of drugs is the most favorable route, the precise mechanism of intestinal epithelial permeation is not well understood. Recently, compelling evidence has emerged to show that absorptive transporters such as OATPs contribute to intestinal drug absorption. Since changes in intestinal transpo...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2013.09.001

    authors: Tamai I,Nakanishi T

    更新日期:2013-12-01 00:00:00

  • Therapeutic strategies to halt renal fibrosis.

    abstract::Angiotensin II blockade has become a standard anti-fibrotic therapy in renal diseases because it slows progression to end-stage renal disease. However, current data support the notion that angiotensin II blockade alone cannot stop progressive fibrotic disease. Of an increasing number of therapies showing efficacy in a...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00144-3

    authors: Yu L,Noble NA,Border WA

    更新日期:2002-04-01 00:00:00

  • Death in pain: peripheral nerve injury and spinal neurodegenerative mechanisms.

    abstract::A complex network operates in the spinal dorsal horn to integrate peripheral nociceptive inputs with local and descending control mechanisms, and to cross-talk with higher brain areas. Injury to peripheral sensory nerves can trigger a cascade of events within this relay which, in some cases, may turn into abnormal res...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.10.021

    authors: Berliocchi L,Russo R,Tassorelli C,Morrone LA,Bagetta G,Corasaniti MT

    更新日期:2012-02-01 00:00:00

  • Opioid-receptor-heteromer-specific trafficking and pharmacology.

    abstract::Homomerization and heteromerization of 7 transmembrane spanning (7TM)/G-protein-coupled receptors (GPCRs) have been an important field of study. Whereas initial studies were performed in artificial cell systems, recent publications are shifting the focus to the in vivo relevance of heteromerization. This is especially...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2009.09.007

    authors: van Rijn RM,Whistler JL,Waldhoer M

    更新日期:2010-02-01 00:00:00

  • Host immune modulation by antimicrobial drugs: current knowledge and implications for antimicrobial chemotherapy.

    abstract::It is known that antimicrobial agents possess several, beneficial, secondary properties which complement their primary antimicrobial activity like the immunomodulatory capacity that enforces host defense mechanisms or reduces host inflammatory response. In this review the current state of our recent research about the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.011

    authors: Banche G,Allizond V,Mandras N,Tullio V,Cuffini AM

    更新日期:2014-10-01 00:00:00

  • Targeting CYP17: established and novel approaches in prostate cancer.

    abstract::There is a growing body of evidence that although medical or surgical castration blocks the generation of gonadal testosterone in prostate cancer, androgens originating from other sources may continue to drive androgen receptor (AR) signaling. Recent studies have demonstrated high intratumoral levels of androgens and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.06.004

    authors: Yap TA,Carden CP,Attard G,de Bono JS

    更新日期:2008-08-01 00:00:00

  • The brain hypocretins and their receptors: mediators of allostatic arousal.

    abstract::The hypocretins (abbreviated 'Hcrts' - also called 'orexins') are two neuropeptides secreted exclusively by a small population of neurons in the lateral hypothalamus. These peptides bind to two receptors located throughout the brain in nuclei associated with diverse cognitive and physiological functions. Initially, th...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.12.018

    authors: Carter ME,Schaich Borg J,de Lecea L

    更新日期:2009-02-01 00:00:00

  • The present state of the tuberculosis drug development pipeline.

    abstract::Tuberculosis now ranks as the leading cause of death in the world due to a single infectious agent. Current standard of care treatment can achieve very high cure rates for drug-sensitive disease but requires a 6-month duration of chemotherapy. Drug-resistant disease requires significantly longer treatment durations wi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.08.001

    authors: J Libardo MD,Boshoff HI,Barry CE 3rd

    更新日期:2018-10-01 00:00:00

  • New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases.

    abstract::Chronic liver diseases with different etiologies represent a major public health issue worldwide. Liver fibrosis is the common feature of almost all chronic liver diseases and remains a key determinant of clinical prognosis. Over the last two decades, basic science studies have uncovered molecular mechanisms underlyin...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.09.006

    authors: Lemoinne S,Friedman SL

    更新日期:2019-12-01 00:00:00

  • Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite.

    abstract::The deployment of artemisinin-based combination therapies (ACTs) has been, and continues to be, integral to reducing the number of malaria cases and deaths. However, their efficacy is being increasingly jeopardized by the emergence and spread of parasites that are resistant (or partially resistant) to the artemisinin ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.07.010

    authors: Martin RE,Shafik SH,Richards SN

    更新日期:2018-10-01 00:00:00

  • Role of adipokines in the control of energy metabolism: focus on adiponectin.

    abstract::Leptin and adiponectin are the major adipokines secreted by fat cells. Leptin effects energy homeostasis by decreasing food intake and by acting on lipogenesis and fatty acid oxidation. Elucidation of the mechanisms of action of adiponectin (Acrp30), a hormone considered to be a major insulin-sensitizing hormone, and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.08.002

    authors: Lafontan M,Viguerie N

    更新日期:2006-12-01 00:00:00

  • Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.

    abstract::In spite of the recent advancement in the molecular characterization of malignant gliomas and medulloblastomas, the treatment of primary brain tumors remains suboptimal. The use of small molecule inhibitors of intracellular signaling pathways, inhibitors of angiogenesis, and immunotherapic agents is limited by systemi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.02.005

    authors: Iacovelli L,Orlando R,Rossi A,Spinsanti P,Melchiorri D,Nicoletti F

    更新日期:2018-02-01 00:00:00

  • GDNF and somatostatin in sensory neurones.

    abstract::Somatostatin (SOM) is a regulatory peptide produced throughout the central nervous system and in most major peripheral organs. In humans, the SOM stable analogue octreotide (OCT) is used to treat opioid-resistant pain. In animal models, SOM and OCT are analgesics and SOM released from the peripheral endings of sensory...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00007-3

    authors: Malcangio M

    更新日期:2003-02-01 00:00:00

  • Epidermal growth factor receptor tyrosine kinase inhibitors.

    abstract::Clinical trials of selective small-molecule inhibitors of epidermal growth factor receptor tyrosine kinase activity have shown that these targeted inhibitors of proliferative signal transduction provide well-tolerated antitumour activity in patients. Preclinical pharmacology studies illustrate the potential use of the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00183-2

    authors: Wakeling AE

    更新日期:2002-08-01 00:00:00

  • Brk/PTK6 signaling in normal and cancer cell models.

    abstract::Breast tumor kinase (Brk), also termed PTK6, is known to function in cell-type and context-dependent processes governing normal differentiation. However, in tumors in which Brk is overexpressed, this unusual soluble tyrosine kinase is emerging as a mediator of cancer cell phenotypes, including increased proliferation,...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2010.08.007

    authors: Ostrander JH,Daniel AR,Lange CA

    更新日期:2010-12-01 00:00:00

  • Regulators of G protein signalling: a spotlight on emerging functions in the cardiovascular system.

    abstract::Regulator of G protein signalling (RGS) proteins are GTPase-activating proteins for heterotrimeric G protein alpha subunits, and are therefore physiologically and pathophysiologically important negative regulators of G-protein-coupled receptor signalling in the cardiovascular system. Owing to the functional redundancy...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.11.007

    authors: Wieland T,Lutz S,Chidiac P

    更新日期:2007-04-01 00:00:00

  • Antiviral therapeutics for the treatment of Ebola virus infection.

    abstract::There have been significant developments in Ebola virus therapeutics. While the efficacy of several products was evaluated in the recent West Africa outbreak, a licensed treatment for EBOV disease remains elusive. Factors that negatively impacted the execution of clinical trials included an overall lack of world readi...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.08.016

    authors: Cardile AP,Downey LG,Wiseman PD,Warren TK,Bavari S

    更新日期:2016-10-01 00:00:00

  • Immunomodulation in stem-cell transplantation.

    abstract::Acute graft-versus-host disease is a complication that affects 30-60% of patients undergoing allogeneic stem-cell transplantation. The standard for prophylaxis for graft-versus-host disease has historically been the combination of cyclosporine and methotrexate. Recently, tacrolimus has been used more frequently and cu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00174-1

    authors: Abo-Zena RA,Horwitz ME

    更新日期:2002-08-01 00:00:00

  • PET imaging: implications for the future of therapy monitoring with PET/CT in oncology.

    abstract::Among the methods based on molecular imaging, the measure of the tracer uptake variation between a baseline and follow-up scan with the SUV and [(18)F]FDG-PET/CT is a very powerful tool for assessing response to treatment in oncology. However, the development of new targeted therapeutics and tissue pharmacokinetic eva...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.07.016

    authors: Tomasi G,Rosso L

    更新日期:2012-10-01 00:00:00

  • GABAB receptor modulation-to B or not to be B a pro-cognitive medicine?

    abstract::Metabotropic GABAB receptors clearly modify cognitive performance in preclinical animal models, yet translation to treating human disease has been elusive. Compared to their ionotropic GABAA receptor counterpart GABAB receptors not only regulate postsynaptic excitability but also regulate diverse synaptic inputs by pr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2017.09.012

    authors: Serrats J,Cunningham MO,Davies CH

    更新日期:2017-08-01 00:00:00

  • Impact of ∼omics in the detection and validation of potential anti-infective drugs.

    abstract::New anti-infective drugs are an unmet necessity of modern medicine. The use of ∼omics technologies has exponentially increased the knowledge on active anti-infective structures, where to search for them and their mechanisms of action. Research involving extreme and unique environments (such as endophytes) revealed the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.008

    authors: Maldonado-Carmona N,Vázquez-Hernández M,Patiño Chávez OJ,Rodríguez-Luna SD,Jiménez Rodríguez O,Sanchez S,Ceapă CD

    更新日期:2019-10-01 00:00:00

  • The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.

    abstract::Hepatocellular carcinoma (HCC) is the 5th most common cancer, but the 3rd leading cause of cancer death globally with approximately 700,000 fatalities annually. The severity of this cancer arises from its difficulty to detect and treat. The major etiologies of HCC are liver fibrosis or cirrhosis from chronic viral inf...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.04.002

    authors: Black AP,Mehta AS

    更新日期:2018-08-01 00:00:00

  • Recent advances in combinatorial drug screening and synergy scoring.

    abstract::Treatment of complex diseases such as cancer, cardiovascular disease, diabetes or neurological disorders frequently warrants the utilization of drug combinations for therapeutic intervention. In fact, the most successful example is the current standard of care for HIV patients. However, identification of successful dr...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2018.07.008

    authors: Pemovska T,Bigenzahn JW,Superti-Furga G

    更新日期:2018-10-01 00:00:00